{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:19:07Z","timestamp":1763018347076,"version":"3.45.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajogmfm.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics & Gynecology MFM"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ajogmf.2021.100394","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T12:57:47Z","timestamp":1620824267000},"page":"100394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Use of the angiogenic biomarker profile to risk stratify patients with fetal growth restriction"],"prefix":"10.1016","volume":"3","author":[{"given":"Gabriel A.","family":"Arenas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nga Y.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariel","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Lopes Perdigao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harjot","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques S.","family":"Abramowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Mussatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiang-Teck J.","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5828-7433","authenticated-orcid":false,"given":"Sarosh","family":"Rana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajogmf.2021.100394_bib0001","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/ajh.2008.20","article-title":"Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004","volume":"21","author":"Wallis","year":"2008","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0002","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","volume":"376","author":"Steegers","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0003","first-page":"261","article-title":"Prediction of adverse outcomes by common definitions of hypertension in pregnancy","volume":"97","author":"Zhang","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0004","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/HJH.0b013e3282f1a953","article-title":"Non-proteinuric pre-eclampsia: a novel risk indicator in women with gestational hypertension","volume":"26","author":"Homer","year":"2008","journal-title":"J Hypertens"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0005","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12884-016-1010-0","article-title":"The diagnosis of pre-eclampsia using two revised classifications in the Finnish Pre-Eclampsia Consortium (FINNPEC) cohort","volume":"16","author":"Kallela","year":"2016","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0006","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/uog.21867","article-title":"Impact of new definitions of pre-eclampsia on incidence and performance of first-trimester screening","volume":"55","author":"Khan","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0007","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG Practice Bulletin, Number 222","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0008","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/jog.14017","article-title":"Does pre-eclampsia without proteinuria lead to different pregnancy outcomes than pre-eclampsia with proteinuria?","volume":"45","author":"Tochio","year":"2019","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0009","first-page":"1122","article-title":"Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy","volume":"122","author":"pregnancy","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0010","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.preghy.2014.02.001","article-title":"The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP","volume":"4","author":"Tranquilli","year":"2014","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0011","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1515\/JPM.2006.089","article-title":"Normal and abnormal transformation of the spiral arteries during pregnancy","volume":"34","author":"Espinoza","year":"2006","journal-title":"J Perinat Med"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0012","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/uog.12280","article-title":"Uteroplacental ischemia in early- and late-onset pre-eclampsia: a role for the fetus?","volume":"40","author":"Espinoza","year":"2012","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0013","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.placenta.2005.12.006","article-title":"The uterine spiral arteries in human pregnancy: facts and controversies","volume":"27","author":"Pijnenborg","year":"2006","journal-title":"Placenta"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0014","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1067\/S0002-9378(03)00576-3","article-title":"The frequency and severity of placental findings in women with preeclampsia are gestational age dependent","volume":"189","author":"Moldenhauer","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0015","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1515\/jpm.2011.098","article-title":"Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia","volume":"39","author":"Ogge","year":"2011","journal-title":"J Perinat Med"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0016","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.earlhumdev.2005.09.005","article-title":"Prediction and prevention of preeclampsia and IUGR","volume":"81","author":"Fayyad","year":"2005","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174399","article-title":"Cluster analysis to estimate the risk of preeclampsia in the high-risk prediction and Prevention of preeclampsia and fetal growth restriction (PREDO) study","volume":"12","author":"Villa","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0018","article-title":"First trimester preeclampsia screening and prediction","author":"Chaemsaithong","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0019","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0020","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0021","article-title":"The diagnostic value of angiogenic and antiangiogenic factors in differential diagnosis of preeclampsia","author":"Verlohren","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0022","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0023","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1161\/HYPERTENSIONAHA.119.13997","article-title":"Angiogenic marker prognostic models in pregnant women with hypertension","volume":"75","author":"Perry","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0024","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/HYPERTENSIONAHA.117.09913","article-title":"Angiogenic markers predict pregnancy complications and prolongation in preeclampsia: continuous versus cutoff values","volume":"70","author":"Saleh","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0025","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","article-title":"Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia","volume":"125","author":"Rana","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126815","article-title":"Circulating angiogenic factors and the risk of adverse outcomes among Haitian women with preeclampsia","volume":"10","author":"March","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.07.037","article-title":"The sFlt-1\/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients","volume":"206","author":"Verlohren","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0028","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/uog.18894","article-title":"Longitudinal change of sFlt-1\/PlGF ratio in singleton pregnancy with early-onset fetal growth restriction","volume":"52","author":"Herraiz","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0029","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.preghy.2018.06.017","article-title":"Clinical implementation of the sFlt-1\/PlGF ratio to identify preeclampsia and fetal growth restriction: a prospective cohort study","volume":"13","author":"Herraiz","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0030","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.preghy.2018.03.013","article-title":"Placental growth factor informed management of suspected pre-eclampsia or fetal growth restriction: the MAPPLE cohort study","volume":"14","author":"Sharp","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0031","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/uog.21949","article-title":"sFlt-1\/PlGF ratio and timing of delivery in early-onset fetal growth restriction with antegrade umbilical artery flow","volume":"56","author":"Quezada","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0032","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/HYPERTENSIONAHA.120.16422","article-title":"Real-world use of biomarkers in management of hypertension during pregnancy: adjunct to clinical care","volume":"77","author":"Suresh","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0033","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1186\/s12913-018-3406-1","article-title":"Economic assessment of the use of the sFlt-1\/PlGF ratio test to predict preeclampsia in Germany","volume":"18","author":"Schlembach","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0034","article-title":"Economic evaluation of the sFlt-1\/PlGF ratio for the short-term prediction of preeclampsia in a Japanese cohort of the PROGNOSIS Asia study","author":"Ohkuchi","year":"2021","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0035","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/01.AOG.0000429658.85846.f9","article-title":"ACOG Practice bulletin no. 134: fetal growth restriction","volume":"121","year":"2013","journal-title":"Obstet Gynecol"},{"year":"2021","series-title":"Research Electronic Data Capture (REDCap)","key":"10.1016\/j.ajogmf.2021.100394_bib0036"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0037","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/uog.19178","article-title":"Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting","volume":"53","author":"Zeisler","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0038","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.preghy.2017.02.005","article-title":"Diagnosis of preeclampsia and fetal growth restriction with the sFlt-1\/PlGF ratio: diagnostic accuracy of the automated immunoassay Kryptor\u00ae","volume":"8","author":"Dr\u00f6ge","year":"2017","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0039","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.preghy.2018.01.001","article-title":"An sFlt-1:PlGF ratio of 655 is not a reliable cut-off value for predicting perinatal outcomes in women with preeclampsia","volume":"11","author":"Stolz","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0040","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.preghy.2020.03.002","article-title":"Correlation of Kryptor and Elecsys\u00ae immunoassay sFlt-1\/PlGF ratio on early diagnosis of preeclampsia and fetal growth restriction: a case-control study","volume":"20","author":"Sim\u00f3n","year":"2020","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0041","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/uog.13190","article-title":"Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE)","volume":"42","author":"Lees","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0042","first-page":"1","article-title":"Births in the United States, 2016","volume":"287","author":"Martin","year":"2017","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0043","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ogc.2017.08.008","article-title":"Evidence-based labor and delivery management: can we safely reduce the cesarean rate?","volume":"44","author":"Caughey","year":"2017","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0044","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3109\/14767058.2014.928689","article-title":"Maternal outcomes according to mode of delivery in women with severe preeclampsia: a cohort study","volume":"28","author":"Amorim","year":"2015","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijgo.2004.03.006","article-title":"Chronic hypertension and the risk for adverse pregnancy outcome after superimposed pre-eclampsia","volume":"86","author":"Vanek","year":"2004","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0046","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/HYPERTENSIONAHA.118.12205","article-title":"Angiogenic factor estimation as a warning sign of preeclampsia-related peripartum morbidity among hospitalized patients","volume":"73","author":"Lopes Perdigao","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0047","doi-asserted-by":"crossref","first-page":"g2301","DOI":"10.1136\/bmj.g2301","article-title":"Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis","volume":"348","author":"Bramham","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0048","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/uog.17493","article-title":"Chronic hypertension and adverse pregnancy outcome: a cohort study","volume":"50","author":"Panaitescu","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0049","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/AOG.0000000000001525","article-title":"Soluble fms-like tyrosine kinase-1-to-placental growth factor ratio and time to delivery in women with suspected preeclampsia","volume":"128","author":"Zeisler","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.preghy.2018.05.011","article-title":"The expression of serum sEGFR, sFlt-1, sEndoglin and PLGF in preeclampsia","volume":"13","author":"Cui","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0051","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.preghy.2018.04.010","article-title":"Predictive value of sFlt-1, PlGF, sFlt-1\/PlGF ratio and PAPP-A for late-onset preeclampsia and IUGR between 32 and 37\u202fweeks of pregnancy","volume":"12","author":"Birdir","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0052","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3109\/14767058.2015.1012063","article-title":"Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population","volume":"29","author":"Kienast","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0053","doi-asserted-by":"crossref","first-page":"e6005","DOI":"10.1097\/MD.0000000000006005","article-title":"Circulating angiogenic factors are related to the severity of gestational hypertension and preeclampsia, and their adverse outcomes","volume":"96","author":"Lea\u00f1os-Miranda","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0054","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/10641955.2013.784788","article-title":"Clinical characterization and outcomes of preeclampsia with normal angiogenic profile","volume":"32","author":"Rana","year":"2013","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0055","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.pedneo.2016.10.005","article-title":"The sFlt-1\/PlGF ratio as a predictor for poor pregnancy and neonatal outcomes","volume":"58","author":"Chang","year":"2017","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.ajogmf.2021.100394_bib0056","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/HYPERTENSIONAHA.120.15146","article-title":"Prediction of preeclampsia-related adverse outcomes with the sFlt-1 (soluble fms-like tyrosine kinase 1)\/PlGF (placental growth factor)-ratio in the clinical routine: a Real-world Study","volume":"77","author":"Dr\u00f6ge","year":"2021","journal-title":"Hypertension"}],"container-title":["American Journal of Obstetrics & Gynecology MFM"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933321000896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933321000896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:47:06Z","timestamp":1762904826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589933321000896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S2589933321000896"],"URL":"https:\/\/doi.org\/10.1016\/j.ajogmf.2021.100394","relation":{},"ISSN":["2589-9333"],"issn-type":[{"type":"print","value":"2589-9333"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of the angiogenic biomarker profile to risk stratify patients with fetal growth restriction","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics & Gynecology MFM","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajogmf.2021.100394","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100394"}}